Clinical trials
Dementia trials in the Netherlands
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
53 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2004 | 1 |
| 2005 | 2 |
| 2006 | 2 |
| 2007 | 1 |
| 2009 | 1 |
| 2011 | 2 |
| 2012 | 3 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 4 |
| 2017 | 3 |
| 2018 | 4 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 4 |
| 2022 | 3 |
| 2023 | 5 |
| 2024 | 4 |
| 2025 | 5 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 19 |
| Recruiting | 11 |
| Terminated | 11 |
| Unknown status | 7 |
| Active, not recruiting | 5 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Radboud University Medical Center | 9 |
| Washington University School of Medicine | 4 |
| Maastricht University Medical Center | 3 |
| Axovant Sciences Ltd. | 2 |
| Bristol-Myers Squibb | 2 |
| FORUM Pharmaceuticals Inc | 2 |
| Janssen Research & Development, LLC | 2 |
| Leiden University Medical Center | 2 |
| Maastricht University | 2 |
| TauRx Therapeutics Ltd | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Dementia | 53 |
| Alzheimer Disease | 32 |
| Cognitive Dysfunction | 15 |
| Brain Diseases | 6 |
| Neurodegenerative Diseases | 5 |
| Mental Disorders | 4 |
| Central Nervous System Diseases | 3 |
| Dementia, Vascular | 3 |
| Frontotemporal Dementia | 3 |
| Lewy Body Disease | 3 |
Trials
Showing 1 to 25 of 53. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.